Evidence map›Paper›PMID 31357576›Full record

ArticleDiagnostics (Basel, Switzerland)2019

Long-Lasting Remission in De Novo Breast Myeloid Sarcoma Treated with Decitabine and Radiotherapy.

Carla Minoia, Vincenza de Fazio, Giovanni Scognamillo, Anna Scattone, Nicola Maggialetti, Cristina Ferrari, Attilio Guarini

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Carla MinoiaHaematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.ORCID 0000-0002-5707-0689
Vincenza de FazioHaematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
Giovanni ScognamilloRadiotherapy Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
Anna ScattonePathology Department, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
Nicola MaggialettiRadiodiagnostic Unit, Dipartmento di Medicina e Scienze della Salute "Vincenzo Tiberio", University of Molise, 86100 Campobasso, Italy.
Cristina FerrariD.I.M.-Diagnostic Imaging-Nuclear Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy. ferrari_cristina@inwind.it.
Attilio GuariniHaematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
Istituto Tumori Bari · ITUniversity of Bari Aldo Moro · ITUniversity of Molise · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloid sarcoma (MS) represents a rare disease with an adverse clinical outcome for patients not candidate to acute myeloid leukemia (AML)-like chemotherapies. Here we present the case of an elderly patient affected by a bilateral breast localization of MS treated with the hypomethylating agent decitabine associated to radiotherapy. The association of the two treatment modalities has allowed an optimal and long-lasting disease control.

Indexed as

acute myeloidbreastdecitabineextramedullaryleukemiamyeloidsarcoma

Identifiers

PMID31357576
PMCPMC6787642
OpenAlexW2965770324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.